Anzeige
Mehr »
Samstag, 04.10.2025 - Börsentäglich über 12.000 News
Innocan Pharma: Neues Medikament für den Massenmarkt?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40D0J | ISIN: SE0022060513 | Ticker-Symbol: IV62
Frankfurt
03.10.25 | 08:06
7,670 Euro
0,00 % 0,000
1-Jahres-Chart
KINNEVIK AB A Chart 1 Jahr
5-Tage-Chart
KINNEVIK AB A 5-Tage-Chart
RealtimeGeldBriefZeit
7,8007,98011:49

Aktuelle News zur KINNEVIK AB A Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.07.Swedish VC Kinnevik hails "encouraging sign" of increased IPO and M&A activity29
KINNEVIK AB A Aktie jetzt für 0€ handeln
08.07.Kinnevik AB: Kinnevik's Interim Report 1 January - 30 June 2025225"Kinnevik concludes a solid second quarter with strong growth and continued margin improvements in our core companies. We also continue to selectively add exciting companies to our portfolio and in...
► Artikel lesen
24.04.Kinnevik AB reports Q1 results9
24.04.Kinnevik AB: Kinnevik's Interim Report 1 January - 31 March 2025296"The start of 2025 has brought volatility and uncertainty across financial markets. This, we are used to. What we are less accustomed to is that it stems from a threat to the global trade system. We...
► Artikel lesen
04.02.Kinnevik AB: Kinnevik's Year-End Release 2024725"Coming out of 2024, Kinnevik now has a predominantly private portfolio invested in growth companies coupled with a strong cash position. While we have around 20 larger investments, our priority in...
► Artikel lesen
16.10.24Kinnevik AB: Kinnevik's Interim Report 1 January - 30 September 2024461"After seven years, the transformation to growth is completed. We enter the next phase of Kinnevik with a strong financial position, and with a growth-focused portfolio consisting of a high-performing...
► Artikel lesen
6 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1